 DUBLIN, Ireland, Oct. 26, 2021 GLOBE NEWSWIRE -- Nabriva Therapeutics plc NASDAQ: NBRV, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it will report its third quarter financial results along with recent company highlights after the close of the U.S. financial markets on Tuesday, November 9, 2021. Nabrivas management will host a conference call at 4:30 p.m. ET to discuss the financial results and recent corporate highlights. 